Open positions
Recent Posts
- Epignostix launches advanced DNA methylation-based sarcoma classifier
- Epignostix announces CMS release of a preliminary gapfill price for their proprietary CPT Code for the Epignostix CNS Tumor Methylation Classifier test
- Epignostix launches CNS and sarcoma diagnostic tumor classifier applications
- Heidelberg Epignostix appoints Helge Lubenow as CEO
- DKFZ spin-off Epignostix raises €4.3m seed round to commercialize diagnostic tumor classifier
Categories
- News 1
- Press Releases 6